Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses
- Conditions
- First Posted Date
- 2008-07-25
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 900
- Registration Number
- NCT00722189
- Locations
- 🇷🇺
Kashkin Clinical Research Mycological Institute, St Petersburg, Russian Federation
Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds
- Conditions
- Interventions
- First Posted Date
- 2008-06-24
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 33
- Registration Number
- NCT00704262
- Locations
- 🇺🇸
Burke Pharmaceuticals, Hot Springs, Arkansas, United States
🇺🇸Dermatology Research of Arkansas, Little Rock, Arkansas, United States
🇺🇸Ameriderm Research, Ormond Beach, Florida, United States
Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds
- Conditions
- Interventions
- First Posted Date
- 2008-06-05
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 1245
- Registration Number
- NCT00691002
- Locations
- 🇵🇱
Latvia - managed by CRO, Warszawa, Poland
🇷🇸Serbia - managed by CRO, New Belgrade, Serbia
🇵🇱Hungary - managed by CRO, Warszawa, Poland
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2008-05-01
- Last Posted Date
- 2015-04-14
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 458
- Registration Number
- NCT00670241
- Locations
- 🇨🇦
Eastern Canada Cutaneous Research Associates Ltd., Halifax, Nova Scotia, Canada
Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds
- Conditions
- Interventions
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2015-04-29
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 782
- Registration Number
- NCT00640822
- Locations
- 🇨🇦
Probity Medical Research, Waterloo, Ontario, Canada
🇫🇷Hôpital de l'Archet, Nice, France
🇬🇧Ninewells Hospital & Medical School, Dundee, United Kingdom
Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)
- Conditions
- Interventions
- First Posted Date
- 2008-02-29
- Last Posted Date
- 2018-09-10
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 773
- Registration Number
- NCT00626795
- Locations
- 🇿🇦
Division of Dermatology, Groote Schuur Hospital, G23, Cape Town, Western Cape, South Africa
🇺🇸Anniston Medical Clinic, Anniston, Alabama, United States
Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 83
- Registration Number
- NCT00617903
Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
- Conditions
- Interventions
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2021-08-31
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 25
- Registration Number
- NCT00506519
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
- Conditions
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2019-12-18
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 8071
- Registration Number
- NCT00475605
- Locations
- 🇺🇸
Children's Memorial Hospital, Chicago, Illinois, United States
🇺🇸Robert S. Berger, White Plains, Maryland, United States
🇺🇸University of Texas - Houston, Houston, Texas, United States
A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily
- First Posted Date
- 2007-01-04
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 98
- Registration Number
- NCT00417937
- Locations
- 🇩🇪
Intendis GmbH, Berlin, Germany